// App-Quantinova.ai

: Systemic medication treatment patterns in Adults with Atopic Dermatitis (AD): Results From the European Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (EUROSTAD)

Researchers

Presenter

  • Marjolein de Bruin-Weller

Principal Investigators

  • Annalisa Patrizi

  • Silvia Mariel Ferrucci

  • Camilla Loi

  • Audrey Nosbaum

  • Andrew Pink

  • Minzhi Liu

  • Moataz Daoud

  • Carden Simcox

Medical Centers

  • University Medical Center Utrecht, Utrecht, Netherlands

  • Univeristy of Bologna, Bologna, Italy

  • IRCCS S. Orsola-Malpighi Polyclinic, Bologna, Italy

  • IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milano, Italy

  • Azienda Ospedaliera-Universitaria di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, Italy

  • Lyon Sud University Hospital, University of Lyon, Lyon, France

  • INSERM U1111, International Center for Infectiology Research, Lyon, France

  • St. John's Institute of Dermatology, Guy’s & St. Thomas’ Hospitals, London, UK

  • Tigermed-BDM Inc., Somerset, NJ, USA and Sanofi, Bridgewater, NJ, USA

  • Sanofi Genzyme, Cambridge, USA

  • Regeneron Pharmaceuticals, Inc., Tarrytown, NY

Locations

  • France

  • Japan

  • Italy

  • Netherlands

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

Disease

  • Atopic Dermatitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved